These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27433728)

  • 1. Preparation of Oxaliplatin-Deoxycholic Acid Derivative Nanocomplexes and In Vivo Evaluation of Their Oral Absorption and Tumor Growth Suppression.
    Jeon OC; Byun Y; Park JW
    J Nanosci Nanotechnol; 2016 Feb; 16(2):2061-4. PubMed ID: 27433728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluation.
    Pangeni R; Choi SW; Jeon OC; Byun Y; Park JW
    Int J Nanomedicine; 2016; 11():6379-6399. PubMed ID: 27942212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
    Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
    Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.
    Pangeni R; Jha SK; Maharjan R; Choi JU; Chang KY; Choi YK; Byun Y; Park JW
    Int J Nanomedicine; 2019; 14():6339-6356. PubMed ID: 31496690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion.
    Choi JU; Maharjan R; Pangeni R; Jha SK; Lee NK; Kweon S; Lee HK; Chang KY; Choi YK; Park JW; Byun Y
    J Control Release; 2020 Jun; 322():13-30. PubMed ID: 32169534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ionic complex of risedronate with positively charged deoxycholic acid derivative: evaluation of physicochemical properties and enhancement of intestinal absorption in rats.
    Park JW; Byun Y
    Arch Pharm Res; 2014 Dec; 37(12):1560-9. PubMed ID: 24254935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats.
    Jeon OC; Seo DH; Kim HS; Byun Y; Park JW
    Eur J Pharm Sci; 2016 Jan; 82():1-10. PubMed ID: 26542347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplex.
    Hwang SR; Seo DH; Byun Y; Park JW
    Int J Nanomedicine; 2016; 11():4231-46. PubMed ID: 27621618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.
    Alam F; Al-Hilal TA; Chung SW; Seo D; Mahmud F; Kim HS; Kim SY; Byun Y
    Biomaterials; 2014 Aug; 35(24):6543-52. PubMed ID: 24816287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.
    Pangeni R; Subedi L; Jha SK; Kweon S; Kang SH; Chang KY; Choi JU; Byun Y; Park JW
    Int J Nanomedicine; 2020; 15():7719-7743. PubMed ID: 33116497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced oral absorption of ibandronate via complex formation with bile acid derivative.
    Park JW; Hwang SR; Jeon OC; Moon HT; Byun Y
    J Pharm Sci; 2013 Feb; 102(2):341-6. PubMed ID: 23233267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine.
    Mahmud F; Jeon OC; Al-Hilal TA; Kweon S; Yang VC; Lee DS; Byun Y
    Mol Pharm; 2015 Jun; 12(6):1911-20. PubMed ID: 25892399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex.
    Kim SK; Lee S; Jin S; Moon HT; Jeon OC; Lee DY; Byun Y
    Mol Pharm; 2010 Jun; 7(3):708-17. PubMed ID: 20361761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative-lipid complex.
    Jha SK; Han HS; Subedi L; Pangeni R; Chung JY; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
    Drug Deliv; 2020 Dec; 27(1):1501-1513. PubMed ID: 33107339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin.
    Pangeni R; Panthi VK; Yoon IS; Park JW
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30213140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS®.
    Kim YH; Lee SJ; Lee SH; Hahn M
    Pharm Dev Technol; 2012; 17(6):677-86. PubMed ID: 23216046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy.
    Maharjan R; Pangeni R; Jha SK; Choi JU; Chang KY; Choi YK; Park JW; Byun Y
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31337061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
    Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
    Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a novel pyridostigmine bromide-phospholipid nanocomplex in improving oral bioavailability.
    Tan QY; Hu NN; Liu GD; Yin HF; Zhang L; Wang H; Lu LY; Zhang JQ
    Arch Pharm Res; 2012 Mar; 35(3):499-508. PubMed ID: 22477197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.